Building on over 10 years’ experience in the software asset management industry, I have been working with stakeholders to help them optimize their contracting policies and processes, establish long-term software management strategies, and negotiate more favorable software license agreements that align with their business goals of lowering costs, reducing risk, while providing optimal flexibility.

I also have a wealth of experience in the areas of software compliance and license management. I am currently Global Head of Software Asset Management at F. Hoffmann La Roche AG and was Head of Global License Operations at Deutsch Post - DHL. I'm also a winner of multiple ITAM industry awards (SAM Project of Year 2016 & ITAM Professional of Year 2018) and have delivered cost savings of over $120 million in the Roche Pharmaceuticals Worldwide SAM program using Aspera SmartTrack and complementary processes and governance. I’m also a committee member of ISO WG21 and founder of Swiss SAM Forum.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims for improving patient access to medical innovations by working with all relevant stakeholders. Twenty-nine medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology; Life Sciences Industry eight years in a row by the Dow Jones Sustainability Indices (DJSI). The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide.